¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Transepidermal elimination disorder, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® obsessive-compulsive disorder ÇÑ±Û °­¹Ú¹ÝÀÀ¼º Àå¾Ö
¼³¸í   
  °­¹Ú»ç°í(obsession)Àº ¹Ýº¹µÇ´Â »ç°í¸¦ ¸»Çϸç, °­¹ÚÇàÀ§(compulsion)´Â ¹Ýº¹µÇ´Â ÇൿÀ» ¸»ÇÑ´Ù. Áݺ¹µÇ´Â »ç°í¿¡ µû¶ó ¹Ýº¹ÀûÀΠÇൿÀ» ¼öÇàÇϴ Àå¾Ö¸¦ ¸»ÇÑ´Ù. À̶§ ¹Ýº¹ÀûÀΠ»ç°í´Â ÀÌ·ÐÀûÀ¸·Î ÀÌÇØµÇÁö ¾Ê´Â °æ¿ì°¡ ¸¹°í, º»Àεµ ÀÌ·± »ç°í°¡ ÀÌÇØµÇÁö ¾Ê´Â´Ù´Â »ç½ÇÀ» ¾Ë°í °íÄ¡·Á°í ÇÏÁö¸¸, Àß µÇÁö ¾Ê´Â´Ù. ¶ÇÇÑ °è¼ÓÀûÀ¸·Î ÀÌ·± »ç°í¿¡ µû¸¥ ¹Ýº¹ÀûÀΠÇൿÀ» Çϸç, ÀÌ·± ÇൿÀ» ¼öÇàÄ¡ ¾ÊÀ» ½Ã, º»ÀÎÀÇ ÀÇÁö¿Í ¹«°üÇϰԠ¸÷½Ã ºÒ¾ÈÇØÇϰí, ÃÊÁ¶ÇØÇÑ´Ù.
¿µ¹® panic disorder ÇÑ±Û °øÈ²Àå¾Ö
¼³¸í   
  ¹Ýº¹µÇ´Â °øÈ²¹ßÀÛ(panic attack: °©ÀÛ½º·± °øÆ÷»óÅÂÀÇ ¹ßº´)°ú ½Å°æ°ú¹ÎÀ» ³ªÅ¸³»´Â °æ¿ì¸¦ ¸»ÇÔ. °øÈ²¹ßÀÛÀº ´Üµ¶À¸·Î ÀϾ±âº¸´Ù´Â ¿À·£ ±äÀå»óÅ¿¡¼­ ÁÖ±âÀûÀ¸·Î ÀϾ´Â Çö»óÀ¸·Î º¸ÀδÙ. °øÈ²¹ßÀÛÀÇ Áõ»óÀº ±Þ°ÝÇÑ ÀÚÀ²½Å°æÀÚ±ØÁõ»óÀ¸·Î È£Èí°ï¶õ, ½ÉÀå¹Úµ¿Ç×Áø, ÈäºÎÅëÁõ, ÈäºÎ¾Ð¹Ú°¨, Áú½Ä°¨, Çö±âÁõ, ºÒ¾ÈÁ¤ÇÑ ´À³¦ µîÀÌ´Ù. ´ë°³ °©ÀÚ±â ÀϾ ¼öºÐµ¿¾È Áö¼ÓÇß´Ù°¡ ¼Ò½ÇµÇ´Â °ÍÀÌ º¸ÅëÀÌ´Ù. µå¹°°Ô´Â ¼ö½Ã°£ Áö¼ÓµÇ±âµµ ÇÑ´Ù. °øÈ²¹ßÀÛÀº ÁÖ±âÀûÀ¸·Î ¹Ýº¹µÇ¸é¼­ ¸¸¼ºÈ­Çϴ °æÇâÀÌ ¸¹´Ù. ½Å°æ°ú¹ÎÀº °øÈ²¹ßÀÛÀÌ ¾ø´Â ½Ã±âÀÇ Áõ»óÀÌ´Ù. °¨´çŰ ¾î·Á¿î °øÈ²¹ßÀÛ¿¡ ´ëÇÑ ¿¹±âºÒ¾È(±× ÀÏÀÌ ÀϾÁö ¾ÊÀ»±î Çϴ ´À³¦ ¶§¹®¿¡ ¿À´Â ºÒ¾È)ÀÌ ÀÖ°í ±× ¶§¹®¿¡ Á¶½É½º·¯¿öÁö°í ÁÖÀ§¸¦ »ìÇǴ Åµµµµ ³ªÅ¸³ª¼­ ½Å°æÀº ±Øµµ·Î ³¯Ä«·Î¿öÁø´Ù. °øÆ÷Àå¾Ö¿¡¼­µµ ÀÌ·± °øÈ²¹ßÀÛÀÌ ¿Ã ¼ö ÀÖÀ¸³ª, ÀÌ °æ¿ì´Â Æ¯º°ÇÑ ´ë»óÀ̳ª »óȲÀÌ Àִ °Í¿¡ ¹ÝÇØ °øÈ²Àå¾Ö´Â ÀÌ·± Æ¯º°ÇÑ »ç°Ç¾øÀÌ ÁÖ±âÀûÀ¸·Î ¹ß»ýÇÑ´Ù. Ä¡·á´Â Ç׺ҾÈÁ¦¿Í ¶§·Î´Â Ç׿ì¿ïÁ¦¸¦ »ç¿ëÇÑ´Ù.
¿µ¹® antisocial personality disorder ÇÑ±Û ¹Ý»çȸÀûÀΰÝÀå¾Ö
¼³¸í   
  Áö¼ÓÀûÀ¸·Î ±×¸®°í ¸¸¼ºÀûÀ¸·Î ¹Ý»çȸÀûÀΠÇൿÀ» Çϴ Á¤½Å°úÀû º´. ´Ù¸¥ »ç¶÷¿¡°Ô Áø½Ç¼ºÀÌ ¾ø°í ´Ù¸¥ »ç¶÷ÀÇ ±Ç¸®³ª ÇÇÇØ¿¡´Â ÀüÇô ¹«°¨°¢Ç졒ʫÜÁö ÀÚ½ÅÀÇ Ãæµ¿°ú ¿å±¸¿¡ ÀÇÇØ¼­ ÇൿÀ» ÇÑ´Ù. ÀÚ½ÅÀÇ ½Ç¼ö¿¡ ´ëÇØ¼­ ´Ù¸¥ »ç¶÷ÀÌ Ãæ°íÇϴ °ÍÀ» ÂüÁö¸øÇϰí Ç×»ó ÀÚ½ÅÀÇ ¸¶À½´ë·Î¸¸ ÇÑ´Ù.
¿µ¹® anxiety disorder ÇÑ±Û ºÒ¾ÈÀå¾Ö
¼³¸í   
  ½É¸®Àû ºÒ¾ÈÁ¤À̳ª ºÒ¾È µîÀ» Á֠Ư¡À¸·Î Çϴ Á¤½Å°úÀû º´ÅÂ. ´ëÇ¥ÀûÀΠ¿¹·Î´Â °øÆ÷Áõ(phobia)¿Í °øÈ²Àå¾Ö(panic disorder), Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder) µîÀÌ ÀÖ´Ù. °øÆ÷ÁõÀ̶õ Æ¯Á¤ÇÑ Àå¼Ò³ª »óȲ¿¡ ´ëÇØ¼­ º´ÀûÀΠºÒ¾ÈÀ» ´À³¢´Â °ÍÀ¸·Î ±¤Àå°øÆ÷Áõ(agoraphobia): Å¹ Æ®ÀΠ°ø°£À» ¹«¼­¿öÇÔ. »çȸ°øÆ÷Ãþ(social phobia): ´Ù¸¥ »ç¶÷¾Õ¿¡ ¼­´Â °ÍÀ» ¹«¼­¿ö ÇÔ. °í¼Ò°øÆ÷Ãþ(acrophobia): ³ôÀº °÷¿¡ °¡´Â °ÍÀ» ¹«¼­¿öÇÔ. ÁøÆó°øÆ÷Áõ(claustrophobia): ¹ÐÆóµÈ °ø°£À» ¹«¼­¿öÇÔ. µ¿¹°°øÆ÷Áõ(zoophobia): µ¿¹°À» º´ÀûÀ¸·Î ¹«¼­¿öÇÔ µîÀ» Æ÷ÇÔÇÑ´Ù. °øÈ²Àå¾Ö(panic disorde)¶õ ¿ÜºÎÀÇ À§ÇèÇÑ ÀÚ±ØÀÌ ¾ø´Âµ¥µµ ºÒ±¸Ç졒ʡ©Àڱ⠱ؽÉÇÑ °øÆ÷¸¦ ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ ½ÉÀåÀÌ ½ÉÇϰԠ¶Ù°Å³ª ½ÄÀº ¶¡À» È긮°í, ½Ç½Å, È£Èí°ï¶õ µîÀÇ Áõ»óÀ» µ¿¹ÝÇÑ´Ù.
  
  Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder)¶õ 1°³¿ùÀÌ»ó Áö¼ÓÀûÀΠºÒ¾ÈÀ» ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ »ç¼ÒÇÑ ÀÏ»óÀÇ ÀÏ¿¡ ´ëÇÑ ºÒ¾ÈÀ» ´À³¢¸ç, ºÒ¾ÈÀÇ ´ë»óÀÌ ¾ø´Â °æ¿ì¿¡´Â ¾ðÁ¦ ºÒ¾ÈÀ» ´À³¥Áö ¸ð¸¥´Ù´Â ºÒ¾È°¨(¿¹±âºÒ¾È)À» È£¼ÒÇÑ´Ù. ´ë°³ ¼è¾à, ¾îÁö·¯¿ò, ¼Õ¶³¸², ¶¡À» È긮´Â µîÀÇ ½ÅüÀû Áõ»óÀ» µ¿¹ÝÇÑ´Ù.
¿µ¹® cyclothymic disorder ÇÑ±Û ¼øÈ¯¼ºÀå¾Ö
¼³¸í   
  ¿ÜºÎÀڱؿ¡ ÀÇÇØ¼­ º¯È­ÇÏÁö ¾Ê´Â Áö¼ÓÀûÀΠ¸¶À½ÀÇ »óÅÂÀΠ±âºÐ(mood)ÀÇ ÀÌ»óÀÌ Àִ Á¤µ¿Àå¾Ö(affective disorder, mood disorder)ÀÇ ÇÑ Á¾·ù. Á¤µ¿Àå¾ÖÀÇ ´ëÇ¥ÀûÀΠº´À¸·Î´Â ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ Áö¼ÓÀûÀ¸·Î ±âºÐÀÌ ¿ì¿ïÇÑ ¿ì¿ïº´(depression)°ú Áö¼ÓÀûÀ¸·Î ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ ±âºÐÀÌ µé¶ß´Â Á¶º´(mania)ÀÌ ÀÖ´Ù. À̱ؼº Àå¾Ö¶õ ¿ì¿ïº´°ú Á¶º´ÀÌ ÁÖ±âÀûÀ¸·Î ¹Ýº¹µÇ´Â Á¤½Åº´°ú Á¶º´¸¸ ÀÖ°í ¿ì¿ïº´Àº ¾ø´Â °æ¿ì¸¦ ¸ðµÎ Æ÷ÇÔÇϴ °³³äÀÌ´Ù. Áï ¿ì¿ïº´ÀÇ À¯¹«¿¡ °ü°è¾øÀÌ Á¶º´ÀÌ ÇѹøÀ̶󵵠Àִ °æ¿ì À̰ÍÀ» À̱ؼº Àå¾Ö¶ó°í ÇÑ´Ù. ¼øÈ¯¼ºÀå¾Ö¶õ À̱ؼº Àå¾Ö¿Í °°ÀÌ ÈïºÐ°ú ¿ì¿ïÀÇ »óŰ¡ ÁÖ±âÀûÀ¸·Î ¹Ýº¹Çϴ °ÍÀº ¸¶Âù°¡ÁöÀÌÁö¸¸ ÈïºÐÀ̳ª ¿ì¿ïÀÇ »óŰ¡ ÈξÀ °æÇÑ °æ¿ì¿¡ »ç¿ëµÇ´Â ¸»ÀÌ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • elimination
    1. Á¦°Å 2. ¼Ò°Å 3. ¹èÃâ 4. µµÅÂ
  • half elimination rate
    ¹Ý°¨·ü
  • immune elimination
    ¸é¿ª¿øÁ¦°Å
  • antisocial personality disorder
    ¹Ý»çȸÀûÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ¹ßÀ½Àå¾Ö
  • asocial personality disorder
    ºñ»çȸÀûÀΰÝÀå¾Ö
  • attention deficit disorder
    ÁÖÀǷ°áÇÌÀå¾Ö
  • attention deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
  • auditory disorder
    û°¢Àå¾Ö, ³­Ã»
  • autistic disorder
    ÀÚÆóÀå¾Ö, ÀÚÆóº´
  • autoimmune disorder
    ÀÚ°¡¸é¿ªÁúȯ
  • autosomal dominant disorder
    º¸Åë¿°»öü¿ì¼ºÁúȯ
  • autosomal recessive disorder
    º¸Åë¿°»öü¿­¼ºÁúȯ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • elimination
    Á¦°Å
  • disorder
    Àå¾Ö, Áúȯ
  • adjustment disorder
    ÀûÀÀÀå¾Ö
  • affective disorder
    Á¤µ¿Àå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • articulation disorder
    ÀÔ¼Ò¸®Àå¾Ö, ¹ßÀ½Àå¾Ö
  • attention-deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
  • autistic disorder
    ÀÚÆóÀå¾Ö, ÀÚÆóº´
  • behavior disorder
    ÇൿÀå¾Ö
  • body dysmorphic disorder
    ½ÅüÃßÇüÀå¾Ö
  • childhood anxiety disorder
    ¼Ò¾ÆºÒ¾ÈÀå¾Ö
  • cognitive disorder
    ÀÎÁöÀå¾Ö
  • communication disorder
    ÀÇ»ç¼ÒÅëÀå¾Ö
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • coordination disorder
    Çùµ¿Àå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transepidermal elimination
    Ç¥ÇÇÅë°úÁ¦°Å
  • elimination
    Á¦°Å
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â
  • immune elimination
    ¸é¿ª¿øÁ¦°Å
  • transepithelial elimination
    »óÇÇÅë°úÁ¦°Å
  • half elimination rate
    ¹Ý°¨·ü
  • adhesion deficiency disorder
    À¯Âø°áÇÌÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö
  • affective disorder
    Á¤µ¿Àå¾Ö, Á¤µ¿º´
  • amnestic disorder
    ±â¾ï»ó½ÇÀå¾Ö
  • anankastic personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • antisocial personality disorder
    ¹Ý»çȸÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ÀÔ¼Ò¸®Àå¾Ö, ¹ßÀ½Àå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half elimination rate
    1/2Á¦°ÅÀ²(ð¶ËÛëÒ), ¹Ý°¨·ü(ÚâÊõ×Ë)
  • half elimination rate
    1/2Á¦°ÅÀ², ¹Ý°¨·ü.
  • immune elimination
    ¸é¿ªÀ̹°Á¦°Å.
  • Body dysmorphic disorder
    ½ÅüÀÌÇüÀå¾Ö(º´)
  • PDDs Pervasive Developmental Disorder
    Àü¹ÝÀû ¹ß´ÞÀå¾Ö
  • PTSD.see Post Traumatic Stress Disorder
    ¿Ü»óÈÄ ½ºÆ®·¹½ºÀå¾Ö(º´)
  • REM sleep behavior disorder
    ·½¼ö¸éÇൿÀå¾Ö(º´)
  • Retts disorder
    ·¹Æ®Àå¾Ö, ·¹Æ®º´
  • SAD, see seasonal affective disorder
    °èÀý¼º Á¤µ¿Àå¾Ö(º´)
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö (¡­Òàî¡äô).
  • acute polymorphic psychotic disorder
    ±Þ¼º ´ÙÇü¼º Á¤½ÅÁõÀû Àå¾Ö(º´)
  • acute stress disorder
    ±Þ¼º ½ºÆ®·¹½º Àå¾Ö(º´)
  • adjustment disorder
    ÀûÀÀÀå¾Ö(º´)
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö(º´), ¼ö¸é Á¶Á¤ Àå¾Ö(º´)
  • affective disorder
    °¨µ¿¼º Á¤½Åº´, Á¤µ¿¼º Á¤½ÅÀå¾Ö(¡­ïñãêî¡äô).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transepidermal elimination
    °æÇÇÁ¦°Å
  • elimination disorder
    ¹è¼³Àå¾Ö, ¹è¼³º´
  • transepidermal water loss
    °æÇÇ ¼öºÐ¼Õ½Ç
  • elimination
    ¹è¼³, ¹èÁ¦, ¹æÃâ, Á¦°Å.
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â.
  • half elimination rate
    1/2Á¦°ÅÀ²(ð¶ËÛëÒ), ¹Ý°¨·ü(ÚâÊõ×Ë)
  • half elimination rate
    1/2Á¦°ÅÀ², ¹Ý°¨·ü.
  • immune elimination
    ¸é¿ªÀ̹°Á¦°Å.
  • transepithelial elimination
    °æ»óÇÇ Á¦°Å
  • wax elimination
    ¿Î½ºÁ¦°Å.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö (¡­Òàî¡äô).
  • acute polymorphic psychotic disorder
    ±Þ¼º ´ÙÇü¼º Á¤½ÅÁõÀû Àå¾Ö(º´)
  • acute stress disorder
    ±Þ¼º ½ºÆ®·¹½º Àå¾Ö(º´)
  • adjustment disorder
    ÀûÀÀÀå¾Ö(º´)
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö(º´), ¼ö¸é Á¶Á¤ Àå¾Ö(º´)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • elimination reaction
    Á¦°Å ¹ÝÀÀ(ð¶ËÛÚãëë)
  • immune elimination
    ¸é¿ª À̹° Á¦°Å(Øóæ¹ì¶Úªð¶ËÛ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • elimination
    ¹è¼³, ¹èÁ¦, ¹æÃâ, Á¦°Å
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â
  • behavior disorder
    ÇൿÁúȯ
  • blood disorder
    Ç÷¾×Áúȯ
  • convulsive disorder
    °æ·Ã¼ºÀå¾Ö
  • disorder
    Àå¾Ö, Áúº´
  • hypothalamic disorder
    ½Ã»óÇϺÎÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
  • neurological disorder
    ½Å°æ°èÀå¾Ö
  • neurotic disorder
    ½Ã°æÁõÀûÀå¾Ö
  • neurovascular disorder
    ½Å°æÇ÷°üÀå¾Ö
  • psychogenic disorder
    ½ÉÀμºÀå¾Ö
  • psychosomatic disorder
    Á¤½Å½ÅüÀå¾Ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
STANDOUT soft thresholding and depth cueing of unspecified techniques
URD unspecified respiratory disease; upper respiratory disease
TEN total enteral nutrition; total excretory nitrogen; toxic epidermal necrolysis; transepidermal neuros...
TEWL transepidermal water loss
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
VCO2 CO2 elimination
GEC Galactose elimination capacity
MIGET Multiple Inert Gas Elimination Technique
T 1/2 The elimination half life
ASD Acute Stress Disorder
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • L87.9
    Transepidermal elimination disorder, unspecified
    »ó¼¼ºÒ¸íÀÇ °æÇ¥ÇÇ ¹èÃ⼺ Àå¾Ö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • unspecified
    ºñƯÀ̼º
    ´Ù¸¥ °ÍÇÏ°í¸¸ Ưº°È÷ °áÇÕÀ» ÇÑ´ÙµçÁö ¹ÝÀÀÇϴ ƯÀ̼ºÀÌ ¾ø´Â.
  • elimination half-life
    ¼Ò½Ç ¹Ý°¨±â
  • wax elimination
    ¿Î½º Á¦°Å
    ¸Å¸ôµÈ ³³ ¿øÇüÀ» °¡¿­ÇÏ¿© ¿Î½º¸¦ Á¦°ÅÇÏ´Â °ÍÀÌ´Ù. °Ç¿­·Î Á¦°ÅÇÏ´Â ¹æ¹ý°ú ²ú´Â ¹°·Î Á¦°ÅÇÏ´Â ¹æ¹ýÀÌ ÀÖ´Ù.
  • acquired disorder
    ÈÄõ¼º Àå¾Ö
    ¼±ÃµÀûÀÌ ¾Æ´Ï°í Ãâ»ý ÈÄ Á¤»óÀûÀÎ ¹ßÀ°¿¡ ÀÌ»óÀÌ »ý±â°Å³ª, º¯È­°¡ ¿À°Å³ª, Àå¾Ö°¡ ÀϾ °Í.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö, ÀûÀÀÀå¾Ö º´
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö, ÀûÀÀ¼º ¼ö¸éÀå¾Ö º´, ¼ö¸é Á¶Á¤ Àå¾Ö, ¼ö¸é Á¶Á¤ Àå¾Ö º´
  • affective disorder
    Á¤µ¿Àå¾Ö
  • antisocial personality disorder
    ¹Ý»çȸÀû ÀÎ°Ý Àå¾Ö
  • anxiety disorder
    ºÒ¾È Àå¾Ö
    °­¹ÚÁõ, ¿Ü»ó ÈÄ ½ºÆ®·¹½ºÀå¾Ö, °øÆ÷Áõ, °øÈ²Àå¾Ö¸¦ Æ÷ÇÔÇÏ´Â ³ÐÀº ÀǹÌÀÇ ½É¸®Àû Áúº´À¸·Î¼­ ºÒ¾È¿¡ ´ëÇÑ ºñÇö½ÇÀûÀ̰í Áö¼ÓÀûÀÎ ´À³¦, ºÒÈ®½Ç¼º, ¹Ì·¡ÀÇ ¿ì·Á³ª À§Çè¿¡ ´ëÇÑ µÎ·Á¿òÀÌ Æ¯Â¡À̸ç, ±äÀå°¨À̳ª ºÒ¾ÈÀ» µ¿¹ÝÇÑ´Ù. À̰ÍÀº ÀûÀÀ ±â´ÉÀÌ Á¦ÇѵǸç, ȯÀÚ¸¦ ¾È½É½Ã۸é Áõ»óÀÌ ¿ÏÈ­µÈ´Ù.
  • articular disorder
    °üÀý Àå¾Ö
  • atypical factitious disorder
    ºñÁ¤Çü °¡À强 Àå¾Ö
  • autoimmune disorder
    ÀÚ°¡ ¸é¿ª Àå¾Ö
    ½Åü°¡ ÀÚ±â Àڽſ¡ ´ëÇØ Àå¾Ö°¡ ÀÖ´Â ¸é¿ª ¹ÝÀÀÀ» ÀÏÀ¸ÄÑ ·ù¸¶Æ¼¼º °üÀý¿°, ÇǺΠ°æÈ­Áõ°ú °°ÀÌ ÀÚ½ÅÀÇ Á¶Á÷ ÆÄ±«¸¦ À¯¹ßÇÏ´Â Áúȯ.
  • autosomal dominant disorder
    »ó¿°»öü ¿ì¼º À¯Àü Áúȯ
  • autosomal recessive disorder
    »ó¿°»öü ¿­¼º Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
carbon dioxide elimination The rate at which carbon dioxide enters the alveolar gas from the blood, equal in the steady state to the metabolic production of carbon dioxide by tissue metabolism throughout the body; units: ml/min STPD or mmol/min.
(05 Mar 2000)
median time to elimination <pharmacology> The time it takes one half of a drug to be eliminated from the body.
(09 Oct 1997)
elimination <pharmacology> The act of expulsion or of extrusion, especially of drug expulsion from the body.
Origin: L. Eliminatio, from limen = threshold
(18 Nov 1997)
elimination diet A diet designed to detect what ingredient of the food causes allergic manifestations in the patient; food items to which the patient may be sensitive are withdrawn separately and successively from the diet until that which causes the symptoms is discovered.
(05 Mar 2000)
elimination disorders Excretory-related psychiatric disorders usually diagnosed in infancy or childhood.
(12 Dec 1998)
elimination half-life <pharmacology> The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent.
(09 Oct 1997)
affective personality disorder A disturbance of feelings or mood expressed as a milder form of depression and related emotional features that colour the whole psychic life and for which psychosocial stressors are believed to play the major role.
(05 Mar 2000)
alcohol amnestic disorder <psychiatry> A mental disorder with brain damage characterised by amnesia, compensatory confabulation, disturbance of attention, and peripheral neuritis. It is usually associated with alcoholism and dietary deficiencies.
(12 Dec 1998)
antisocial personality disorder <psychiatry> An individual who engages in deviant behaviour with lack of remorse.
(13 Jan 1998)
asthenic personality disorder A personality type characterised by low energy level, easy fatigability, incapacity for enjoyment, lack of enthusiasm, and oversensitivity to physical and emotional stress. When appearing in marked form it becomes a psychological disorder (asthenic personality disorder), also called dependent personality.
Synonym: asthenic personality disorder, dependent personality disorder.
(05 Mar 2000)
attention deficit disorder An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
attention deficit disorder with hyperactivity A behaviour disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood.
(12 Dec 1998)
attention deficit hyperactivity disorder <psychiatry> A condition seen in children where there is increased motor activity in association with poor attention span. Often treated with amphetamine medications.
(27 Sep 1997)
autistic disorder autism, infantile autism
autonomic disorder Disorganization of autonomic processes.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • elimination
    Á¦°Å;¹èÃâ;¿¹¼±;¼Ò°Å
  • unspecified
    Ư±â
  • disorder
    ºÎÁ¶È­
  • disorder
    ¹«Áú¼­;È¥¶õ;È¥¶õ½ÃŰ´Ù;º´µé°ÔÇÏ´Ù
  • mental disorder
    Á¤½Å Âø¶õ 6
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á